This study is looking at a medicine called PF-08642534 for people who have obesity (too much body weight). Researchers want to find out if different amounts of PF-08642534 are safe and how well people tolerate them. They also want to understand how the body uses and removes the medicine. You might be able to join if you are between 18 and 70 years old, have a Body Mass Index (BMI) between 30.0 and 40.0 kg/m², and are generally healthy. People with certain medical conditions, like diabetes or significant heart problems, cannot participate. The main goal is to track any side effects you might experience up to 8 weeks after your last dose.

Study design

This is an interventional study planning to enroll 120 participants. Some participants will receive PF-08642534 once a day, while others will receive a placebo (an inactive substance) once a day.

What's involved

You will go through a screening period of up to 4 weeks to see if you meet the study requirements.

Compensation

Not stated in the trial record.

Follow-up

You will be monitored for side effects up to 8 weeks after your last dose of the study medicine.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.